| First Author | Ishii Y | Year | 2024 |
| Journal | Exp Mol Pathol | Volume | 140 |
| Pages | 104939 | PubMed ID | 39426027 |
| Mgi Jnum | J:357795 | Mgi Id | MGI:7750966 |
| Doi | 10.1016/j.yexmp.2024.104939 | Citation | Ishii Y, et al. (2024) Impaired immunoproteasomal function exacerbates renal ischemia-reperfusion injury. Exp Mol Pathol 140:104939 |
| abstractText | Oxidative stress caused by reactive oxygen species (ROS) is involved in the pathogenesis of renal ischemia-reperfusion injury (I/R injury), a major cause of acute kidney injury and delayed graft function (DGF). DGF is an early transplant complication that worsens graft prognosis and patient survival, but the underlying molecular changes are unclear. The proteasome is a multicatalytic enzyme complex that degrades both normal and damaged proteins, and recent studies have revealed that the immunoproteasome, a specific proteasome isoform whose proteolytic activity enhances the generation of antigenic peptides, plays critical roles in the cellular response against oxidative stress. In this study, we demonstrate the impact of the immunoproteasome in human DGF and in a mouse model of I/R injury. In patients with DGF, the expression of beta5i, a specific immunoproteasome subunit, was decreased in vascular endothelial cells. In a mouse model, beta5i knockout (KO) exacerbated renal I/R injury. KO mice showed greater inflammation, oxidative stress, and endothelial damage compared with wild-type mice. Impaired immunoproteasomal activity also caused increased cell death, ROS production, and expression of inflammatory factors in mouse renal vascular endothelial cells under conditions of hypoxia and reoxygenation. In conclusion, reduced expression of the immunoproteasomal catalytic subunit beta5i exacerbates renal I/R injury in vivo, potentially increasing the risk of DGF. Further research targeting beta5i expression in DGF could lead to the development of novel therapeutic strategies and biomarkers. |
